Tarttelin E E, Gregory-Evans C Y, Bird A C, Weleber R G, Klein M L, Blackburn J, Gregory-Evans K
Department of Molecular Genetics, Imperial College School of Medicine, London, UK.
J Med Genet. 2001 Jun;38(6):381-4. doi: 10.1136/jmg.38.6.381.
Autosomal dominant drusen is of particular interest because of its phenotypic similarity to age related macular degeneration. Currently, mutation R345W of EFEMP1 and, in a single pedigree, linkage to chromosome 6q14 have been causally related to the disease. We proposed to investigate and quantify the roles of EFEMP1 and the 6q14 locus in dominant drusen patients from the UK and USA.
Molecular genetic analysis.
Ten unrelated families and 17 young drusen patients.
Exons 1 and 2 of EFEMP1 were characterised by 5' rapid amplification of cDNA ends and direct sequencing. Exons 1-12 of EFEMP1 were then investigated for mutation by direct sequencing. A HpaII restriction digest test was constructed to detect the EFEMP1 R345W mutation. Marker loci spanning the two dominant drusen linked loci were used to generate haplotype data.
Only seven of the 10 families (70%) and one of the 17 sporadic patients (6%) had the R345W mutation. The HpaII restriction digest test was found to be a reliable and quick method for detecting this. No other exonic or splice site mutation was identified. Of the three families without EFEMP1 mutation, two were linked to the 2p16 region.
EFEMP1 R345W accounts for only a proportion of the dominant drusen phenotype. Importantly, other families linked to chromosome 2p16 raise the possibility of EFEMP1 promoter sequence mutation or a second dominant drusen gene at this locus. Preliminary haplotype data suggest that the disease gene at the 6q14 locus is responsible for only a minority of dominant drusen cases.
常染色体显性遗传性玻璃膜疣因其与年龄相关性黄斑变性的表型相似性而备受关注。目前,EFEMP1基因的R345W突变以及在一个家系中与6号染色体q14区域的连锁关系已被证实与该病存在因果关联。我们提议对来自英国和美国的显性遗传性玻璃膜疣患者中EFEMP1基因和6q14位点的作用进行研究和定量分析。
分子遗传学分析。
10个无亲缘关系的家系和17名年轻的玻璃膜疣患者。
通过5' cDNA末端快速扩增和直接测序对EFEMP1基因的外显子1和2进行特征分析。随后通过直接测序对EFEMP1基因的外显子1至12进行突变检测。构建了HpaII限制性酶切试验以检测EFEMP1基因的R345W突变。使用跨越两个显性遗传性玻璃膜疣连锁位点的标记位点生成单倍型数据。
10个家系中仅有7个(70%)以及17名单发患者中的1个(6%)存在R345W突变。发现HpaII限制性酶切试验是检测该突变的可靠且快速的方法。未鉴定出其他外显子或剪接位点突变。在3个无EFEMP1基因突变的家系中,有2个与2p16区域连锁。
EFEMP1基因的R345W突变仅占显性遗传性玻璃膜疣表型的一部分。重要的是,与2号染色体p16区域连锁的其他家系提示存在EFEMP1基因启动子序列突变或该位点存在第二个显性遗传性玻璃膜疣基因的可能性。初步的单倍型数据表明,6q14位点的致病基因仅导致少数显性遗传性玻璃膜疣病例。